These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Mechanism of long non-coding RNA-metastasis associated lung adenocarcinoma transcript 1 induced invasion and metastasis of esophageal cancer cell EC-109].
    Author: Zhang QQ, Cui YH, Wang Y, Kou WZ, Cao F, Cao XJ, Miao ZH, Kang XH.
    Journal: Zhonghua Zhong Liu Za Zhi; 2017 Jun 23; 39(6):405-411. PubMed ID: 28635228.
    Abstract:
    Objective: To investigate the effect and mechanism of long non-coding RNA-metastasis associated lung adenocarcinoma transcript 1, (LncRNA-MALAT1) on invasion and metastasis of esophageal cancer cell EC-109. Methods: EC-109 cells were transfected with lentiviral vector carrying short hairpin RNA of MALAT1( shRNA-MALAT1) or a nonspecific shRNA control (shRNA-control). The expressions of MALAT1, microRNA-200a, ZEB1 and ZEB2 were detected by qRT-PCR. The effect of shRNA-MALAT1 on invasion of EC-109 cells was determined by transwell assay. The expressions of components of epithelial-msenchymal transition pathway in EC-109 cells were determined by immunofluorescence array and western blotting. The expression relationship between MALAT1 and miR-200a in EC-109 cells was detected by dual-luciferase reporter assay. Results: The result of qRT-PCR showed that the expressions levels of MALAT1, ZEB1 and ZEB2 in shRNA-MALAT1 group were 0.43±0.06, 0.64±0.04 and 0.51±0.04, respectively, significantly lower than 0.97±0.08, 1.06±0.07 and 0.98±0.05 in shRNA-control group and 1 in control group, respectively(all P<0.05). Transwell assay showed that the number of invaded cells in shRNA MALAT1 group was (96.81±10.43) per low-power field, markedly lower than that of (278.44±13.28) per low-power field in shRNA-control group (P<0.01). Immunofluorescence staining and Western blotting showed that MALAT1 downregulation significantly reduced the expressions of proteins related to EMT signal pathway in EC-109 cells.Dual luciferase reporter assay showed that compared to negative control, the activities of luciferase reporter in EC-109 cells co-transfected with pmirGLO-MALAT1-wt and miR-200a were significantly down-regulated. While co-transfected pmirGLO-MALAT1-mut with miR-200a mimics had no effect on the luciferase reporter activities of MALAT1. Conclusion: LncRNA MALAT1 functions as a competing endogenous RNA to regulate the expressions of ZEB1 and ZEB2 by sponging miR-200a and promotes invasion and migration of esophageal cancer cells through inducing epithelial-mesenchymal transition. 目的: 观察长链非编码RNA-肺腺癌转移相关转录子1(LncRNA-MALAT1)对食管癌细胞EC-109侵袭和转移的影响,并探讨其可能的作用机制。 方法: 应用慢病毒载体shRNA对照、shRNA-MALAT1转染EC-109细胞,采用实时荧光定量PCR法检测EC-109细胞中LncRNA-MALAT1、miR-200a、ZEB1和ZEB2 mRNA的表达;采用细胞侵袭实验检测EC-109细胞的侵袭能力;采用免疫荧光、Western blot法检测EC-109细胞中上皮间质转化(EMT)信号通路相关蛋白的表达;采用双荧光素酶报告基因实验检测EC-109细胞中MALAT1与miR-200a表达的关系。 结果: 实时荧光定量PCR检测结果显示,未转染组、转染shRNA对照组和转染shRNA-MALAT1组EC-109细胞中MALAT1 mRNA的相对表达量分别为1.00、0.97±0.08和0.43±0.06,转染shRNA-MALAT1组EC-109细胞中MALAT1 mRNA的表达明显降低(P<0.01)。未转染组、转染shRNA对照组和转染shRNA-MALAT1组EC-109细胞中ZEB1 mRNA的相对表达量分别为1.00、1.06±0.07和0.64±0.04,ZEB2 mRNA的相对表达量分别为1.00、0.98±0.05和0.51±0.04,转染shRNA-MALAT1组EC-109细胞中ZEB1和ZEB2 mRNA的相对表达量均明显降低(均P<0.05)。转染shRNA-MALAT1组的EC-109细胞的穿膜细胞数为(96.81±10.43)个/低倍视野,与转染shRNA对照组EC-109细胞的穿膜细胞数[(278.44±13.28)个/低倍视野]比较,差异有统计学意义(P<0.01)。免疫荧光和Western blot法检测结果显示,沉默EC-109细胞中MALAT1基因的表达可下调EMT信号通路相关蛋白的表达。双荧光素酶报告基因实验结果显示,与转染miRNA阴性对照组比较,共转染pmirGLO-MALAT1-wt和miR-200a模拟物可明显减少EC-109细胞的荧光素酶活性,而共转染pmirGLO-MALAT1-mut和miR-200a模拟物不能抑制EC-109细胞的荧光素酶活性。 结论: LncRNA-MALAT1可能作为竞争性内源RNA,竞争性结合miR-200a,从而上调EC-109细胞中ZEB1和ZEB2的表达,促进EMT进程,导致食管癌的侵袭和转移。.
    [Abstract] [Full Text] [Related] [New Search]